Finance

Lists
Why is 300138 down 3.51%?
Dive Deeper
300138:SHE
Chenguang Biotech Group Co Ltd
CN¥11.26
-3.51%
(-0.41) 1D
Oct 14, 3:04:28 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300138...
Open
CN¥11.63
High
CN¥11.79
Low
CN¥11.21
Mkt. cap
5.64B
Avg. vol.
6.39M
Volume
7.88M
Dividend
2.66%
Quarterly dividend
CN¥0.08
Ex-dividend date
May 21, 2026
P/E ratio
16.36
52-wk high
CN¥15.80
52-wk low
CN¥8.71
EPS
CN¥0.69
Shares outstanding
483.10M
No. of employees
2K
Open
CN¥11.63
High
CN¥11.79
Low
CN¥11.21
Mkt. cap
5.64B
Avg. vol.
6.39M
Volume
7.88M
Dividend
2.66%
Quarterly dividend
CN¥0.08
Ex-dividend date
May 21, 2026
P/E ratio
16.36
52-wk high
CN¥15.80
52-wk low
CN¥8.71
EPS
CN¥0.69
Shares outstanding
483.10M
No. of employees
2K
News stories
From web sources and news partners
About Chenguang Biotech Group Co Ltd
CEO-
Employees2.08K
FoundedApr 12, 2000
Headquarters-
SectorFood
Websitecn-cg.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.39B
1.51B
1.63B
1.53B
Cost of goods sold
1.15B
1.42B
1.41B
1.33B
Cost of revenue
1.15B
1.42B
1.41B
1.33B
Research and development expenses
47.11M
6.75M
33.29M
36.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
67.39M
45.84M
49.61M
49.89M
Operating expense
105.01M
75.42M
80.85M
95.64M
Total operating expenses
1.26B
1.49B
1.49B
1.43B
Operating income
133.00M
18.09M
142.00M
99.65M
Other non operating income
4.98M
-2.66M
-5.48M
3.17M
EBT including unusual items
105.49M
67.52M
113.88M
98.32M
EBT excluding unusual items
140.83M
14.91M
119.78M
76.14M
Income tax expense
15.41M
3.98M
15.48M
12.43M
Effective tax rate
14.61%
5.89%
13.59%
12.65%
Other operating expenses
-11.81M
16.85M
-1.67M
9.72M
Net income
88.86M
65.04M
96.72M
81.81M
Net profit margin
6.39%
4.30%
5.94%
5.35%
Earnings per share
-
-
-
-
Interest and investment income
15.01M
20.93M
12.24M
14.37M
Interest expense
-11.28M
-20.79M
-28.98M
-31.19M
Net interest expenses
3.73M
143.27K
-16.74M
-16.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
174.56M
63.72M
187.63M
143.16M
Gain or loss from assets sale
3.98M
-1.46M
-
-29.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps